Organization · Venture Capital

Awaken Capital

Awaken Capital is an early-stage venture capital firm based in the United States, focusing on tech-enabled platforms and the entrepreneurs behind them. Established in 2023 as the successor to OS Fund, it employs a platform-based investment strategy across various sectors, particularly in life sciences and advanced materials.

Venture CapitalFunder

Overview

What Awaken Capital does

What Awaken Capital is

Awaken Capital is an early-stage venture capital firm based in the United States, focusing on tech-enabled platforms and the entrepreneurs behind them. Established in 2023 as the successor to OS Fund, it employs a platform-based investment strategy across various sectors, particularly in life sciences and advanced materials.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Venture Capital
Founded
Founded in 2023
Approximate age
About 3 years
Structured capabilities
Funder
Last reviewed
May 5, 2026

Official channels

Find Awaken Capital elsewhere

Open the official website or a supported primary organization account.

Capability profile

Awaken Capital as a funder

Investment thesis

Awaken Capital focuses on investing in tech-enabled platforms that address large-scale problems across multiple markets. They believe that platform-based companies generate premium returns by diversifying risk and applying cross-market learnings.

Focus narrative

Awaken Capital invests in meaningful innovations that tackle large-scale challenges. Their focus is on tech-enabled platforms rather than single products, believing that these platforms will lead to the most successful companies of the future. The firm is particularly interested in sectors such as life sciences, synthetic biology, and advanced materials.

Value beyond capital

Awaken Capital provides value to its portfolio companies through a platform mindset, leveraging their expertise in technology and market insights to help entrepreneurs scale their innovations. The firm supports founders with a strong vision and the potential to create foundational infrastructure across multiple markets.

Availability

Currently deploying
Yes

Portfolio and track record

Recorded portfolio count
24
Recorded notable exits
Ginkgo Bioworks, Sprout Social, and Synthego

Portfolio context

Notable prior investments include: Ginkgo Bioworks: A synthetic biology platform for engineered organisms across pharma, agriculture, and industrial applications. Eat Just: A food technology company known for its plant-based products. Numat: A company focused on advanced materials. Numerion Labs: A firm specializing in data-driven solutions. Pivot Bio: A company that develops sustainable agricultural solutions. Sprout Social: A social media management platform. Truvian: A health technology company. Verge Genomics: A biotechnology company focused on drug discovery.

Common questions

What to know about Awaken Capital

Upseed classifies Awaken Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

May 5, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.